Where is Johnson & Johnson headquartered?

Johnson & Johnson's global headquarters is located at 1 Johnson & Johnson Plaza, New Brunswick, New Jersey 08933. The campus serves as the base for the Chairman and CEO, the full executive committee, corporate finance, legal, HR, and global communications. New Brunswick has been J&J's home since the company's 1886 founding — one of the longest corporate-headquarters relationships of any Fortune 500 company with a single city.

J&J is one of the largest private-sector employers in New Jersey and has invested heavily in the redevelopment of downtown New Brunswick over decades, funding arts institutions, affordable housing, and the Robert Wood Johnson University Hospital campus — named after the company's founding family. As of June 2026, there are no announced plans to relocate J&J's global headquarters.

In the U.S. Mid-Atlantic corridor, J&J's largest sites beyond HQ are in Raritan, NJ (MedTech global operations and procurement), Titusville, NJ (Janssen US pharmaceutical commercial operations and medical affairs), and Spring House, PA (historic Janssen R&D campus). These sites are all within a 60-mile radius of New Brunswick, creating an unusually tight geographic cluster for such a large global company.

Internationally, the Janssen campus in Beerse, Belgium is arguably the most strategically important non-HQ site — it is where Darzalex, Stelara, Tremfya, Talvey, and other blockbusters originated, and where the majority of J&J's global R&D leadership is based. On the U.S. West Coast, significant presence exists in San Diego (MedTech and biotech R&D) and Irvine, California (vision care / Acuvue manufacturing). Asia-Pacific hubs in Shanghai, Tokyo, and Singapore handle commercial operations and regulatory affairs for the fastest-growing geographic markets.

J&J's buyer concentration is heaviest in the U.S. Mid-Atlantic corridor — New Brunswick, Raritan, Titusville, and Spring House are all within a 60-mile radius in New Jersey/Pennsylvania. This geographic clustering makes in-person executive access unusually feasible: a single field sales trip to the Princeton–New Brunswick corridor can cover multiple J&J decision-maker groups in one day.

For enterprise technology vendors, the CIO organization (HQ-based in New Brunswick) and the Innovative Medicine commercial IT team (Titusville-adjacent) are natural first-meeting targets. For life sciences R&D or clinical data platform vendors, Beerse, Belgium is the R&D epicenter and requires a dedicated European field presence. Asia-Pacific offices in Shanghai and Tokyo are increasingly autonomous procurement centers for regionally specific tools — particularly as J&J scales its China pharmaceutical business and Japanese MedTech operations. The DePuy Synthes separation will create a new standalone entity with its own headquarters and procurement function, likely to be established in 2026–2027.